View presentations from our most recent event: San Diego-Women & MPN Conference.
Seattle, WA- January 28, 2016
March 17, 2016-San Mateo, CA
- September is National Blood Cancer Awareness Month
We keep you informed of MPN-related Clinical Trial Updates and News:
Get the latest news on MPN research, clinical trials, treatments, education, and advocacy.
- Check out MPN Advocacy and Education Newsletter
- Join Us in Seattle, WA
- Study Finds Link to Cancer & Agent Orange
- CTI BioPharma Completes pre-NDA Meeting on Pacritinib
Patient & Caregiver Support
Join with other patients to learn more about your disease and treatment options through an in-person or online support group. Many major cities throughout the United States and internationally host regular meetings. Contact Ann Brazeau if you are interested in establishing a new Support Group for your area : 517.899.6889 email@example.com
Our scientific advisor is Dr. Ruben Mesa of the Mayo Clinic. He is a frequent speaker at our events. Read more about Dr. Mesa.
Free Patient Info Pack
Give us your address and we’ll send you a free informational package in the mail. Your contact information will be kept strictly confidential. Sign Up Now
What is a myeloproliferative neoplasm? MPNs are a group of rare blood cancers that overproduce blood cells in the bone marrow, and are caused by genetic mutations in the blood stem cells:
- Myelofibrosis is a rare bone marrow cancer. Bone marrow cells that produce blood cells develop and function abnormally resulting in fibrous scar tissue formation.
- Polycythemia Vera is a disorder in which the bone marrow makes too many red blood cells. It may also result in the production of too many other types of blood cells – white blood cells and platelets.
- Essential Thrombocythemia causes the body to produce too many blood platelets-thrombocytes. It can cause abnormal clotting or bleeding. The bone marrow makes too many platelet-forming cells or megakaryocytes, which release platelets into your blood.